Effectiveness of COVID-19 booster vaccination strategies in partially vaccinated populations
Boosters wane but showed protection against hospitalization during omicron, CDC study says - The Washington Post
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Durability of Bivalent Boosters against Omicron Subvariants | NEJM
Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel | NEJM
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet
Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA
Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine | FDA
COVID-19 vaccine breakthrough infections | Science
Are COVID-19 vaccine boosters needed? | Virology Blog
Protection duration after vaccination or infection, and efficacy of a third dose by vaccination or booster by infection – Swiss National COVID-19 Science Task Force
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases
COVID-19 vaccine surveillance report: week 44
COVID-19 Vaccine Boosters at VA Long Beach and New Website
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases
Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study - The Lancet Respiratory Medicine
Booster needed to neutralize the fast-spreading variant | World Economic Forum
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines | The Scientist Magazine®
Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021 | MMWR
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Covid booster vaccines effective against severe illness from omicron, CDC says
COVID-19 BOOSTER VACCINE EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION – in reducing breakthrough, duration of benefit
Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study - The Lancet Infectious Diseases
